UPDATE: Alexion (ALXN) Peers Ramp
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/13/2026
- Nasdaq falls ahead of earnings, economic data while oil rallies
- Oil prices rise on Saudi Arabia attacks, overshadowing Trump's diesel deal
- Will surging equity supply derail the U.S. bull market? Goldman Sachs weighs in
- Broadcom CEO says many AI investors are gamblers
- "Not buying Chipotle": Starbucks squashes blockbuster acquisition speculation
- Bausch + Lomb names Appio interim CEO as Saunders departs
- Cerebras Systems hits new 52-week low on unlock concerns
- Getty Images to go private via prepackaged Chapter 11 restructuring
- Kroger (KR) To Cut Corporate Workforce By About 3,000 Over 3 Years - Bloomberg
- Sysco calls on Teamsters to end LA strike after economic deal reached
Alexion Pharma's (ALXN) High Price Tag Has Many Questioning Roche Deal
July 15, 2013 10:47 AM EDTOn Friday, shares of Alexion Pharmaceuticals Inc. (Nasdaq: ALXN) moved higher on reports it was being targeted by Roche. According to Reuters' sources, Roche is seeking billions in order to finance a $130/share bid. However, given the size, many are skeptical.
"Our EU pharma team is very skeptical about the likelihood of this deal... More



